Association of midlife lipids with 20‐year cognitive change: A cohort study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Introduction: Existing studies predominantly consider the association of late‐life lipid levels and subsequent cognitive change. However, midlife rather than late‐life risk factors are often most relevant to cognitive health. Methods: We quantified the association between measured serum lipids in midlife and subsequent 20‐year change in performance on three cognitive tests in 13,997 participants of the Atherosclerosis Risk in Communities study. Results: Elevated total cholesterol, low‐density lipoprotein cholesterol, and triglycerides were associated with greater 20‐year decline on a test of executive function, sustained attention, and processing speed. Higher total cholesterol and triglycerides were also associated with greater 20‐year decline in memory scores and a measure summarizing performance on all three tests. High‐density lipoprotein cholesterol was not associated with cognitive change. Results were materially unchanged in sensitivity analyses addressing informative missingness. Discussion: Elevated total cholesterol, low‐density lipoprotein cholesterol, and triglycerides in midlife were associated with greater 20‐year cognitive decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 1×
“Accelerated cognitive decline is also itself a concern, even if it never progresses to dementia;[11] therefore, risk factors for cognitive change represent potential targets for intervention with the dual goal of improving quality of life and preventing dementia.”
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Midlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238
Cardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883 · cited 1×
“One prior study found no association between midlife total cholesterol and 6-year cognitive change (visits 2–4) [41].”
Self-citationSolomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000231980 · Cited by 557
Gottesman, R. F., Schneider, A. L. C., Albert, M., Alonso, A., Bandeen-Roche, K., Coker, L., Coresh, J., Knopman, D., Power, M. C., Rawlings, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1646 · Cited by 474 · cited 3×
“For context, the estimated magnitude of excess cognitive decline on the DSST contrasting those with “bad” to “good” lipid levels is approximately 1/2 to 3/4 of what we observed for having one APOE ε4 allele, an established risk factor for Alzheimer’s disease dementia, and is in the range of the magnitude of effect pre…”
InfluentialSelf-citationKalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417
Dyslipidemia and the Risk of Alzheimer’s Disease
Reitz, C. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0307-3 · Cited by 190
Statins, cognition, and dementia-systematic review and methodological commentary
Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.35 · Cited by 150 · cited 1×
“Finally, despite evidence from our study and others linking midlife lipids to late-life cognition, the current evidence suggests that use of statins does not protect against dementia, at least in the near term [43].”
Self-citationBlood Pressure and Cognition: Factors That May Account for Their Inconsistent Association
Power, M. C., Tchetgen Tchetgen, E. J., Sparrow, D., Schwartz, J., & Weisskopf, M. G. (2013) · Epidemiology · doi:10.1097/ede.0b013e3182a7121c · Cited by 63
Self-citation
Cited by
Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study
Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Gross, A. L., Mosley, T. H., Selvin, E., & Windham, B. G. (2019) · Neurology · doi:10.1212/wnl.0000000000007094 · Cited by 282
“Given evidence for steeper rates of cognitive decline after midlife,(18) this spline term allowed us to model a nonlinear association between time and cognitive decline in amanner that fits our study design, while also allowing the effect of midlife inflammation to vary across time.(19,20) An interaction term between…”
MethodSelf-citationSchultz, B. G., Patten, D. K., & Berlau, D. J. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0110-3 · Cited by 229
“However, high TC in late-life was not associated with mild cognitive impairment (MCI), Alzheimer’s disease, vascular dementia, any dementia, or cognitive decline [46].”
BackgroundA Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
Picard, C., Nilsson, N., Labonté, A., Auld, D., Rosa‐Neto, P., Initiative, T. A. D. N., Ashton, N. J., Zetterberg, H., Blennow, K., Breitner, J. C. B., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12442 · Cited by 66
“3,4 In recent months, two parallel lines of evidence have suggested that circulating LDL levels play an active role in the pathogenesis of early-onset familial Alzheimer’s disease (EOAD).”
Gul, R., Jan, H., Lalay, G., Andleeb, A., Usman, H., Zainab, R., Qamar, Z., Hano, C., & Abbasi, B. H. (2021) · Coatings · doi:10.3390/coatings11060717 · Cited by 33
Metadata
- Authors
- Power, M. C., Rawlings, A., Sharrett, A. R., Bandeen‐Roche, K., Coresh, J., Ballantyne, C. M., Pokharel, Y., Michos, E. D., Penman, A., Alonso, A., Knopman, D., Mosley, T. H., & Gottesman, R. F.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2017-09-12
- Volume
- 14
- Issue
- 2
- Pages
- 167-177
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2754237832
- Cited by
- 146
- References
- 10
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of midlife lipids with 20‐year cognitive change: A cohort study. https://app.cochat.ai/papers/10.1016/j.jalz.2017.07.757
- The paper
- Power, M. C., Rawlings, A., Sharrett, A. R., Bandeen‐Roche, K., Coresh, J., Ballantyne, C. M., Pokharel, Y., Michos, E. D., Penman, A., Alonso, A., Knopman, D., Mosley, T. H., & Gottesman, R. F. (2018). Association of midlife lipids with 20‐year cognitive change: A cohort study. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2017.07.757
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.